Henry Uppal

PHD Doctor of Philosophy,  Charité - Universitätsmedizin Berlin 

Location: India

Consulting Services

Legal Support Scientific Writing Career Advice and Mentoring Data Science-Bioinformatics

Areas Of Interest

Injections, Endolymphatic Disease Job-related Stresses Syk-Related Tyrosine Kinase Fractures, Medial Malleolus COX 2 Inhibitors Isoflavone Derivatives Animals, Axenic Interleukin-10 Receptor alpha Subunit Vesicle, Transport Replication Factor A Single Stranded DNA Binding Protein Antigen, CD158b Mal de Meleda Leukemia, Lymphocytic, Chronic, B-Cell U-72107A Precursor Cells, Granulocytic Insufficiency, Exocrine Pancreatic Scleritis, Necrotizing Lymphoblastic Leukemia, Acute, T Cell Retroviruses, Simian Learning, Hierarchical Recombinases Pontis, Nucleus Pigmentosus Community Health Workers Dermatosis, Hand Grafts, Allogeneic Safety Seats, Child Humor, Aqueous Workman's Compensations Mannose-6-Phosphate Isomerase Mediators, Lymphocyte Cytochrome P450 Superfamily TGF beta Type II Receptors Aminoform Serologic Test Daphniphyllum calycinums Leishmania viannias Supravalvar Aortic Stenosis Syndrome

Professional Narrative

Dr. Henry Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 2012
Director Medicine, Harvard Med 1994

Education

Director Medicine, Harvard Medical School 1989
Master of Science in physician assistant, Weill Medical College 1993

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :